Emergency Medicine Continuing Medical Education
Be part of the knowledge.™Episodes 1-15 of 67
Cracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
CME/CECracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
A Roadmap to Safe and Effective Bispecific Antibody Use in Myeloma: Mitigating and Managing Adverse Events
CME/CEA Roadmap to Safe and Effective Bispecific Antibody Use in Myeloma: Mitigating and Managing Adverse Events
Considerations for Dosing Bispecific Antibodies
MinuteCE®Considerations for Dosing Bispecific Antibodies
Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
MinuteCE®Approved Bispecific Antibodies for RRMM: Review of the Pivotal Trials
Integrating Bispecific Antibodies Into Clinical Practice
MinuteCE®Integrating Bispecific Antibodies Into Clinical Practice
Clinical Challenges With Triple-Class or Penta-Refractory MM
MinuteCE®Clinical Challenges With Triple-Class or Penta-Refractory MM
Bispecific Antibodies: The Newest Immunotherapy on the Block for RRMM
MinuteCE®Bispecific Antibodies: The Newest Immunotherapy on the Block for RRMM
The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
MinuteCE®The Evolving Treatment Paradigm for RRMM: The Role of Bispecific Antibodies
Efficacy Data for Bispecific Antibodies in RRMM
MinuteCE®Efficacy Data for Bispecific Antibodies in RRMM
Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
MinuteCE®Step-Up Dosing of Bispecific Antibodies: The Need for Hospitalization
Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
MinuteCE®Preventing CRS and Neurotoxicities Related to Bispecific Antibodies
Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
MinuteCE®Managing Infections, Cytopenias, and Other AEs Related to Bispecific Antibodies
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
MinuteCE®Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
MinuteCE®Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
